Senate follow-on biologics hearing
Executive Summary
The Senate Committee on Health will hold a March 8 hearing on follow-on biologics. Sen. Charles Schumer, D-N.Y., reintroduced generic biologics legislation, noting that it should be attached to the reauthorization of the Prescription Drug User Fee Act and that the bill has the support of Committee Chairman Ted Kennedy, D-Mass. (1"The Pink Sheet" Feb. 19, 2007, p. 3)...